DRUG · Unmapped registry intervention
PF-06291874
Find medicine records ·
Find other trials using this name
Clinical trial
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
NCT02554877
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
PF-06291874DRUG
PlaceboDRUG
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
HoustonTexas, United States2TorontoOntario, Canada2Los AngelesCalifornia, United States1St LouisMissouri, United States1MiamiFlorida, United States1San AntonioTexas, United States1ColumbusOhio, United States1IndianapolisIndiana, United States1Las VegasNevada, United States1RichmondVirginia, United States1OrangeCalifornia, United States1HonoluluHawaii, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02554877 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.